Assessing Progression of Biologic Therapies Based on Smoking Status in Patients With Crohn’s Disease
Assessing Progression of Biologic Therapies Based on Smoking Status in Patients With Crohn’s Disease
About this item
Full title
Author / Creator
Publisher
US: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Abstract
Background
Active smoking is a well-established risk factor for developing Crohn’s disease (CD) and negatively impacts overall disease progression. Patients who start or continue smoking after CD diagnosis are at risk for poor outcomes, higher therapeutic requirements, and have higher rates of relapse. However, it remains unclear if...
Alternative Titles
Full title
Assessing Progression of Biologic Therapies Based on Smoking Status in Patients With Crohn’s Disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11063538
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11063538
Other Identifiers
ISSN
1078-0998,1536-4844
E-ISSN
1536-4844
DOI
10.1093/ibd/izad131
